Baseline characteristics | |
Age years | 61 (52–68) |
Sex, male | 26 (52) |
BMI kg·m−2 | 28 (27–34) |
BMI group | |
Normal (18.5–24.9 kg·m−2) | 5 (10) |
Overweight (25–29.9 kg·m−2) | 26 (52) |
Obese (>30 kg·m−2) | 19 (38) |
Comorbidities | |
Hypertension | 21 (42) |
Dyslipidaemia | 14 (28) |
Diabetes mellitus | 12 (24) |
COPD | 4 (8) |
Asthma | 3 (6) |
Active malignancy | 3 (6) |
SAHS | 3 (6) |
Ischaemic heart disease | 1 (2) |
Chronic renal disease | 1 (2) |
Smoking history | |
Never | 33 (66) |
Former | 10 (20) |
Current | 2 (4) |
Unknown | 5 (10) |
Charlson Comorbidity Index | 2 (1–4) |
Clinical characteristics | |
SOFA | 6.5 (4.5–7) |
Invasive mechanical ventilation days | 11 (8–22) |
Prolonged mechanical ventilation (≥21 days) | 13 (26) |
Tracheostomy | 11 (22) |
Re-intubation | 6 (12) |
Pulmonary thromboembolism | 9 (18) |
Continuous neuromuscular blockade | 46 (92) |
Systemic corticosteroids during admission# | 50 (100) |
Length of stay in ICU days | 15 (12–29) |
Length of stay post-ICU days | 7.5 (6–13) |
Length of stay in hospital days | 27.5 (23–45) |
Supplemental O2 | |
Hospital discharge | 27 (54) |
3 months follow-up visit | 3 (6) |
6 months follow-up visit | 2 (4) |
Hospital discharge destination | |
Home | 20 (40) |
Home with follow-up physiotherapy | 15 (30) |
Inpatient rehabilitation | 13 (26) |
Home with outpatient physiotherapy | 2 (4) |
Data are presented as median (25th–75th percentile) for continuous variables and n (%) for categorical variables. BMI: body mass index; SAHS: sleep apnoea–hypopnoea syndrome; SOFA: sequential organ failure assessment; ICU: intensive care unit. #: course of intravenous dexamethasone.